Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Post by Stylesson Jun 22, 2015 1:44pm
80 Views
Post# 23855900

Look at all the promoting going on here...

Look at all the promoting going on here...Some say 15 to 25. Another says 50, maybe 100.

It's 10.59 right now. Relax guys.

The biotech / healthcare market is up large this year (IBB up 26% ytd). Every canadian pharma company is up at least 60-100% year to date. This stock is down 36%. You really think there's that kind of upside in CPH? You're dreaming. If there's even a blip of a pullback in this monster long rally in Biotech/healthcare, CPH is going down with it.

You're best to stick with the winners in this sub sector bull run. The losers will get punished on the macro pullback.

It's a funny read though. If Absorbica picks up market share, CPH will do this and that...big IFs being thrown out there. GLTA, but you'll never see 25 bucks on this name. Not unless they do something transformational. This one trick pony is getting tired.
Bullboard Posts